vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and BRAND HOUSE COLLECTIVE, INC. (TBHC). Click either name above to swap in a different company.
BRAND HOUSE COLLECTIVE, INC. is the larger business by last-quarter revenue ($103.5M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). BRAND HOUSE COLLECTIVE, INC. runs the higher net margin — -3.6% vs -70.9%, a 67.3% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -9.6%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-26.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -21.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Soho House is an international private members’ club with a focus on the media, arts and fashion industries.
CTKB vs TBHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $103.5M |
| Net Profit | $-44.1M | $-3.7M |
| Gross Margin | 52.9% | 20.4% |
| Operating Margin | -9.0% | -1.9% |
| Net Margin | -70.9% | -3.6% |
| Revenue YoY | 8.1% | -9.6% |
| Net Profit YoY | -557.1% | 51.8% |
| EPS (diluted) | — | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $103.5M | ||
| Q3 25 | $52.3M | $75.8M | ||
| Q2 25 | $45.6M | $81.5M | ||
| Q1 25 | $41.5M | $148.9M | ||
| Q4 24 | $57.5M | $114.4M | ||
| Q3 24 | $51.5M | $86.3M | ||
| Q2 24 | $46.6M | $91.8M | ||
| Q1 24 | $44.9M | $165.9M |
| Q4 25 | $-44.1M | $-3.7M | ||
| Q3 25 | $-5.5M | $-20.2M | ||
| Q2 25 | $-5.6M | $-11.8M | ||
| Q1 25 | $-11.4M | $7.9M | ||
| Q4 24 | $9.6M | $-7.7M | ||
| Q3 24 | $941.0K | $-14.5M | ||
| Q2 24 | $-10.4M | $-8.8M | ||
| Q1 24 | $-6.2M | $10.1M |
| Q4 25 | 52.9% | 20.4% | ||
| Q3 25 | 52.7% | 16.3% | ||
| Q2 25 | 52.3% | 24.9% | ||
| Q1 25 | 48.6% | 30.3% | ||
| Q4 24 | 58.5% | 28.1% | ||
| Q3 24 | 56.3% | 20.5% | ||
| Q2 24 | 54.6% | 29.5% | ||
| Q1 24 | 51.3% | 32.0% |
| Q4 25 | -9.0% | -1.9% | ||
| Q3 25 | -17.6% | -24.7% | ||
| Q2 25 | -23.3% | -12.9% | ||
| Q1 25 | -36.1% | 6.2% | ||
| Q4 24 | 5.2% | -2.1% | ||
| Q3 24 | -8.2% | -15.4% | ||
| Q2 24 | -18.3% | -8.2% | ||
| Q1 24 | -23.9% | 6.4% |
| Q4 25 | -70.9% | -3.6% | ||
| Q3 25 | -10.5% | -26.6% | ||
| Q2 25 | -12.2% | -14.5% | ||
| Q1 25 | -27.5% | 5.3% | ||
| Q4 24 | 16.8% | -6.7% | ||
| Q3 24 | 1.8% | -16.8% | ||
| Q2 24 | -22.4% | -9.6% | ||
| Q1 24 | -13.8% | 6.1% |
| Q4 25 | — | $-0.16 | ||
| Q3 25 | — | $-0.90 | ||
| Q2 25 | — | $-0.54 | ||
| Q1 25 | — | $0.61 | ||
| Q4 24 | — | $-0.59 | ||
| Q3 24 | — | $-1.11 | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $6.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-44.0M |
| Total Assets | $461.5M | $229.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $6.5M | ||
| Q3 25 | $93.3M | $3.6M | ||
| Q2 25 | $75.5M | $3.5M | ||
| Q1 25 | $95.3M | $3.8M | ||
| Q4 24 | $98.7M | $6.8M | ||
| Q3 24 | $162.3M | $4.5M | ||
| Q2 24 | $177.9M | $3.8M | ||
| Q1 24 | $168.8M | $3.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.0M | ||
| Q4 24 | — | $85.8M | ||
| Q3 24 | — | $61.4M | ||
| Q2 24 | — | $47.5M | ||
| Q1 24 | — | $34.0M |
| Q4 25 | $341.7M | $-44.0M | ||
| Q3 25 | $378.6M | $-35.2M | ||
| Q2 25 | $377.6M | $-16.2M | ||
| Q1 25 | $379.6M | $-19.0M | ||
| Q4 24 | $395.7M | $-27.1M | ||
| Q3 24 | $385.5M | $-19.7M | ||
| Q2 24 | $389.1M | $-5.5M | ||
| Q1 24 | $392.6M | $3.1M |
| Q4 25 | $461.5M | $229.2M | ||
| Q3 25 | $494.9M | $221.9M | ||
| Q2 25 | $493.3M | $225.4M | ||
| Q1 25 | $482.6M | $242.2M | ||
| Q4 24 | $499.5M | $279.8M | ||
| Q3 24 | $491.2M | $266.2M | ||
| Q2 24 | $483.7M | $242.6M | ||
| Q1 24 | $492.1M | $250.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-25.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $-26.8M |
| FCF MarginFCF / Revenue | -2.9% | -25.9% |
| Capex IntensityCapex / Revenue | 1.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-18.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-25.9M | ||
| Q3 25 | $-3.9M | $-7.0M | ||
| Q2 25 | $108.0K | $-3.1M | ||
| Q1 25 | $-125.0K | $19.8M | ||
| Q4 24 | $2.0M | $-12.6M | ||
| Q3 24 | $13.2M | $-12.7M | ||
| Q2 24 | $6.2M | $-13.7M | ||
| Q1 24 | $4.0M | $28.2M |
| Q4 25 | $-1.8M | $-26.8M | ||
| Q3 25 | $-4.6M | $-7.4M | ||
| Q2 25 | $-1.5M | $-3.6M | ||
| Q1 25 | $-974.0K | $19.0M | ||
| Q4 24 | $1.1M | $-13.1M | ||
| Q3 24 | $12.2M | $-13.2M | ||
| Q2 24 | $5.2M | $-14.4M | ||
| Q1 24 | $3.4M | $26.7M |
| Q4 25 | -2.9% | -25.9% | ||
| Q3 25 | -8.7% | -9.8% | ||
| Q2 25 | -3.2% | -4.5% | ||
| Q1 25 | -2.3% | 12.8% | ||
| Q4 24 | 1.9% | -11.5% | ||
| Q3 24 | 23.7% | -15.2% | ||
| Q2 24 | 11.0% | -15.7% | ||
| Q1 24 | 7.6% | 16.1% |
| Q4 25 | 1.6% | 0.9% | ||
| Q3 25 | 1.3% | 0.6% | ||
| Q2 25 | 3.5% | 0.7% | ||
| Q1 25 | 2.0% | 0.5% | ||
| Q4 24 | 1.6% | 0.4% | ||
| Q3 24 | 2.0% | 0.5% | ||
| Q2 24 | 2.3% | 0.8% | ||
| Q1 24 | 1.3% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.51× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
TBHC
Segment breakdown not available.
